AI Demand Boosts cannabis stocks on London Market
cannabis stocks listed in London gain investor interest as AI demand and digital infrastructure create measurable revenue through automation, software and
Top Stories
View All
Argent Trades medical cannabis Rights to Splash in $5.5M Deal
medical cannabis company Argent BioPharma (RGT) has sold global commercialisation rights to its epilepsy drug CannEpil to Splash Beverage Group in a US$5.5 million licensing-and-debt-restructuring…
Medicine
View All
Data
View All
WCO: Morocco ranks fifth in cannabis seizures
cannabis seizures in 2025 placed Morocco fifth worldwide, with authorities intercepting 37.8 tonnes, according to the World Customs Organization (WCO)…
North American Cannabis Holdings enterprise value falls
enterprise value for North American Cannabis Holdings (OTC:USMJ) does not display a reported EV/EBIT forward on TradingView; the platform shows…
cannabis data breach exposes 1.08M member IDs
cannabis data breach exposed 1,082,680 club member records after a researcher found an unsecured backend used by dozens of Spanish…
UN Report Says Cannabis Use Rises 40% Globally
The United Nations Office on Drugs and Crime (UNODC) reports that global cannabis use reached 256 million people in 2024,…
Categories
Editorial
View All
AI Demand Boosts cannabis stocks on London Market
cannabis stocks listed in London are attracting renewed investor attention as demand for artificial intelligence capacity and upgrades to digital infrastructure reshape capital flows. Investors…
